Vivos Therapeutics Inc. - רווח נקי למניה אחת בשנים עשר החודשים האחרונים VVOS

Vivos Therapeutics is optimizing international medical device delivery through a carrier pool, which enhances operational resilience. The year-over-year change in EPS (TTM) visualizes profit dynamics, with the value -10.30 capturing this metric. Growth relies on insurance companies' recognition of apnea treatment systems, while the scaling of the subscription model and the implementation of software in clinics create the primary growth potential.
Vivos Therapeutics Inc. - פילוחים אנליטיים ומדדי מפתח (VVOS)

To identify stability drivers, investors must track earnings per share dynamics, where the current EPS YoY shift over the last 12 months compares total annual income with the same period of the previous cycle. This indicator reflects the commercialization efficiency of non-invasive sleep apnea treatment devices, signaling the ability of Vivos Therapeutics (VVOS) to scale its share in respiratory medicine across B2B and B2C segments.